Cellular Biomedicine Group (Cellular Biomedicine Group) Margin of Safety % (DCF Earnings Based) : N/A (As of May. 07, 2024)

View and export this data going back to 2007. Start your Free Trial

What is Cellular Biomedicine Group Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Cellular Biomedicine Group's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

Competitive Comparison of Cellular Biomedicine Group's Margin of Safety % (DCF Earnings Based)

For the Biotechnology subindustry, Cellular Biomedicine Group's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cellular Biomedicine Group's Margin of Safety % (DCF Earnings Based) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cellular Biomedicine Group's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Cellular Biomedicine Group's Margin of Safety % (DCF Earnings Based) falls into.

Cellular Biomedicine Group Margin of Safety % (DCF Earnings Based) Related Terms

Thank you for viewing the detailed overview of Cellular Biomedicine Group's Margin of Safety % (DCF Earnings Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Cellular Biomedicine Group (Cellular Biomedicine Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cellular Biomedicine Group Inc (NAS:CBMG) » Definitions » Margin of Safety % (DCF Earnings Based)

Comparable Companies

Traded in Other Exchanges

N/A

Address

1345 Avenue of Americas, 15th Floor, New York, NY, USA, 10105

Website

http://www.cellbiomedgroup.com

Cellular Biomedicine Group Inc is a biotechnology company focused on the development of proprietary cell therapies for the treatment of cancer and degenerative diseases. The company has two major cell platforms: immune cell therapy for treating a broad range of cancers using cancer vaccines, Chimeric Antigen Receptor T-cell technologies, and anti-PD-1 technologies; and human-adipose-derived mesenchymal progenitor cells for treatment of joint and autoimmune diseases. The immuno-oncology and stem cell research team is based in both China and the United States.

Executives

Ag Novartis	10 percent owner	LICHTSTRASSE 35, BASEL V8 CH 4056
Pharma Ag Novartis	10 percent owner	LICHTSTRASSE 35, CH-4002, BASEL V8
Edward T Schafer	director	1400 31ST AVENUE SW, SUITE 60, MINOT ND 58701
Wen Tao Liu	director	530 UNIVERSITY AVENUE, #17 PALO ALTO CA 94301
Terry Belmont	director	530 UNIVERSITY DRIVE PALO ALTO CA 94301
Au Chun Kwok Alan	director	C/O CELLULAR BIOMEDICINE GROUP, INC. 530 UNIVERSITY AVENUE, #17 NEW YORK NY 94301
Hansheng Zhou	director	369 LUMO ROAD HONGSHAN DISTRICT WUHAN F4 430074
Gang Jacky Ji	director	XIXI RONGZHUANG 27-3 JINGCHANG ROAD, YUHANG DISTRICT, HANGZHOU, ZHEJIANG F4 311100
Viktor Pan	10 percent owner	HELI XI LU 183 NO. 531 SHANGHAI F4 201317
Srl Opea	director	VIA CESARE BATTISTA 1 MILAN L6 20122
Zheng Zhou	10 percent owner	FLAT B, 25/F, TOWER 6, MARINELLA 9 WELFARE ROAD, ABERDEEN HONG KONG K3 00000
Sailing Capital Overseas Investments Fund, Lp	10 percent owner	C/O UNIT 2006-08, 20F HARBOUR CENTRE 25 HARBOUR ROAD WAN CHAI K3 00000
Maplebrook Ltd	10 percent owner	P.O. BOX 31119 GRAND PAVILLION HIBISCUS WAY, 802 WEST BAY ROAD GRAND CAYMAN E9 KY1-1205
Tf Venture Capital Management Co., Ltd.	10 percent owner	PO BOX 472, 2ND FLOOR, HARBOUR PLACE 103 SOUTH CHURCH STREET, GEORGE TOWN GRAND CAYMAN E9 KY1-1106
Winsor Capital Ltd	10 percent owner	TRINITY CHAMBERS PO BOX 4301, ROAD TOWN TORTOLA D8 00000